Melatech is partner of multiple research projects aimed at advancing healthcare technology. As a partner in the Artificial Intelligence in Smart Clinical research consortium (AISC), we focus on integrating AI-driven solutions to enhance clinical decision-making.
Through the Dermoscopic Augmented Histology Trial (DAHT), we investigate whether providing pathologists with pre-removal images of lesions improves the accuracy and efficiency of histopathological evaluations.
Our involvement in SynTIA contributes to developing an AI system to assist dermatologists in diagnosing skin cancer more quickly and accurately.
Additionally, our collaboration on PRSONAL is dedicated to personalizing healthcare delivery through AI-driven insights, optimizing patient care and resource allocation.